|
21 Sep 2007 |
Novo Nordisk receives approval in the EU for use of NovoRapid(R) in elderly people
|
|
20 Sep 2007 |
Zelos Therapeutics Presents Positive Data at ASBMR on Subcutaneous and Inhaled Delivery of Cyclic PTH (1-31) (Ostabolin-C(TM))
|
|
20 Sep 2007 |
Teva Provides Update on Edratide for Systemic Lupus Erythematosus
|
|
19 Sep 2007 |
New Data Support Long-Term Efficacy and Safety in Patients Who Took Exubera for Eight Years
|
|
19 Sep 2007 |
Sinobiomed Updates on Clincial Trial Success for Recombinant Batroxobin (rBat)
|
|
19 Sep 2007 |
Acceleron Pharma Presents Positive Phase 1 Results Demonstrating ACE-011 Increases Markers of Bone Formation
|
|
18 Sep 2007 |
A major pharmaceutical company has taken an exclusive option to BA058, a compound licensed by Ipsen to Radius in 2005
|
|
18 Sep 2007 |
SYGNIS' AX200 shows efficacy in stroke patients
|
|
15 Sep 2007 |
Novartis completes agreement with Bayer Schering related to Betaseron(R) rights and manufacturing
|
|
15 Sep 2007 |
Phase 3 study confirms that liraglutide treatment leads to both glucose and weight reduction with a low risk of hypoglycaemic events
|
|
14 Sep 2007 |
Targanta Initiates Phase 2 Oritavancin Infrequent Dosing Study
|
|
14 Sep 2007 |
FDA Advisory Committees Recommend Continued US Marketing Authorization for Trasylol
|
|
13 Sep 2007 |
Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program
|
|
12 Sep 2007 |
Phosphagenics to commence Phase 2 TPM/Insulin cinical trial
|
|
12 Sep 2007 |
Amgen to Review Benefits, Risks of ESA Therapy in Chronic Renal Failure Patients at FDA Advisory Committee
|
|
12 Sep 2007 |
Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery
|
|
11 Sep 2007 |
Neose Announces Initiation of Phase II Renal Trial of NE-180
|
|
11 Sep 2007 |
Lev Pharmaceuticals Meets Primary Endpoint in Pivotal Phase III Prophylactic Trial for Hereditary Angioedema
|
|
11 Sep 2007 |
Palatin Technologies Announces Reacquisition of Full Rights to Bremelanotide Program
|
|
11 Sep 2007 |
First Ever Therapy Targets Optic Nerve Head for Glaucoma
|
|
07 Sep 2007 |
FDA has approved Zealand Pharma's Investigative New Drug application
|
|
07 Sep 2007 |
Aranesp(R) Study Showing No Negative Impact on Survival in SCLC Presented at World Conference on Lung Cancer
|
|
06 Sep 2007 |
Pieris validates the use of Anticalins(R) as ophthalmologic biotherapeutics
|
|
05 Sep 2007 |
ThromboGenics Announces Successful Completion of Technology Transfer to
|
|
04 Sep 2007 |
GTC obtains FDA fast track designation for Atryn(R) and permission to submit a rolling BLA
|
